Unexpected presence of the neurotrophins NGF and BDNF and the neurotrophin receptor p75 in the tendon cells of the human Achilles tendon

Histology and Histopathology

Volumn 24, Issue 7, 2009, Pages 839-848

  Bagge, Johan ^a   Lorentzon, Ronny ^a   Alfredson, Håkan ^a   Forsgren, Sture ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Achilles tendon; Neurotrophins; NGF; p75; Tendinopathy

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUORESCENT DYE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; RHODAMINE; TETRAMETHYLRHODAMINE ISOTHIOCYANATE;

ACHILLES TENDON; ADULT; ARTICLE; CHRONIC DISEASE; CYTOLOGY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TENDINITIS;

ACHILLES TENDON; ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; RECEPTOR, NERVE GROWTH FACTOR; RHODAMINES; TENDINOPATHY; YOUNG ADULT;

EID: 68849091797     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Alfredson H. (2005). The chronic painful Achilles and patellar tendon: research on basic biology and treatment. Scand. J. Med. Sci. Sports. 15, 252-259.
2. Aloe L. (2004). Nerve growth factor, human skin ulcers and vascularization. Our experience. Prog. Brain. Res. 146, 515-522.
3. Aloe L., Probert L., Kollias G., Micera A. and Tirassa P. (1995). Effect of NGF antibodies on mast cell distribution, histamine and substance P levels in the knee joint of TNF-arthritic transgenic mice. Rheumatol. Int. 14, 249-252.
4. Andersson G., Danielson P., Alfredson H. and Forsgren S. (2008). Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul. Pept. 150, 81-87.
5. Asaumi K., Nakanishi T., Asahara H., Inoue H. and Takigawa M. (2000). Expression of neurotrophins and their receptors (TRK) during fracture healing. Bone 26, 625-633.
6. Aspenberg P. and Virchenko O. (2004). Platelet concentrate injection improves Achilles tendon repair in rats. Acta. Orthop. Scand. 75, 93-99.
7. Bjur D., Alfredson H. and Forsgren S. (2005). The innervation pattern of the human Achilles tendon: studies of the normal and tendinosis tendon with markers for general and sensory innervation. Cell Tissue Res. 320, 201-206.
8. Bjur D., Danielson P., Alfredson H. and Forsgren S. (2008a). Presence of a non-neuronal cholinergic system and occurrence of up- and down-regulation in expression of M2 muscarinic acetylcholine receptors: new aspects of importance regarding Achilles tendon tendinosis (tendinopathy). Cell Tissue Res. 331, 385-400.
9. Bjur D., Danielson P., Alfredson H. and Forsgren S. (2008b). Immunohistochemical and in situ hybridization observations favor a local catecholamine production in the human Achilles tendon. Histol. Histopathol. 23, 197-208.
10. Caporali A., Pani E., Horrevoets A.J., Kraenkel N., Oikawa A., Sala- Newby G.B., Meloni M., Cristofaro B., Graiani G., Leroyer A.S., Boulanger C.M., Spinetti G., Yoon S.O., Madeddu P. and Emanueli C. (2008). Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ. Res. 103, 15-26.
11. Chapman B.S. and Kuntz I.D. (1995). Modeled structure of the 75-kDa neurotrophin receptor. Protein. Sci. 4, 1696-1707.
12. Chu G.K., Yu W. and Fehlings M.G. (2007). The p75 neurotrophin receptor is essential for neuronal cell survival and improvement of functional recovery after spinal cord injury. Neuroscience 148, 668-682.
13. Danielson P., Alfredson H. and Forsgren S. (2006). Immunohistochemical and histochemical findings favoring the occurrence of autocrine/paracrine as well as nerve-related cholinergic effects in chronic painful patellar tendon tendinosis. Microsc. Res. Tech. 69, 808-819.
14. Danielson P., Alfredson H. and Forsgren S. (2007a). Studies on the importance of sympathetic innervation, adrenergic receptors, and a possible local catecholamine production in the development of patellar tendinopathy (tendinosis) in man. Microsc Res. Tech. 70, 310-324.
15. Danielson P., Alfredson H. and Forsgren S. (2007b). In situ hybridization studies confirming recent findings of the existence of a local nonneuronal catecholamine production in human patellar tendinosis. Microsc. Res. Tech. 70, 908-911.
16. de Mos M., van der Windt A.E., Jahr H., van Schie H.T., Weinans H., Verhaar J.A. and van Osch G.J. (2008). Can platelet-rich plasma enhance tendon repair? A cell culture study. Am. J. Sports Med. 36, 1171-1178.
17. Friess H., Zhu Z.W., di Mola F.F., Kulli C., Graber H.U., Andren- Sandberg A., Zimmermann A., Korc M., Reinshagen M. and Buchler M.W. (1999). Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann. Surg. 230, 615-624.
18. Funakoshi H., Frisen J., Barbany G., Timmusk T., Zachrisson O., Verge V.M. and Persson H. (1993). Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J. Cell Biol. 123, 455-465.
19. Gillardon F., Eschenfelder C., Rush R.A. and Zimmerman M. (1995). Increase in neuronal Jun immunoreactivity and epidermal NGF levels following UV exposure of rat skin. Neuroreport 6, 1322-1324.
20. Gonzalez R.R., Fong T., Belmar N., Saban M., Felsen D. and Te A. (2005). Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. J. Urol. 173, 630-634.
21. Grimsholm O., Guo Y., Ny T. and Forsgren S. (2008). Expression patterns of neurotrophins and neurotrophin receptors in articular chondrocytes and inflammatory infiltrates in knee joint arthritis. Cells Tissues Organs 188, 299-309.
22. Halliday D.A., Zettler C., Rush R.A., Scicchitano R. and McNeil J.D. (1998). Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Neurochem. Res. 23, 919-922.
23. Hansson M. and Forsgren S. (1995). Immunoreactive atrial and brain natriuretic peptides are co-localized in Purkinje fibres but not in the innervation of the bovine heart conduction system. Histochem. J. 27, 222-230.
24. Iannone F., Bari C., Dell'Accio F., Covelli M., Patella V., Lo Bianco G., Lapdula G. (2002). Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p40 TrkA) in human osteoarthritic chondrocytes. Rheumatol. (Oxford). 41, 1413-1418.
25. Ibanez C.F. (1998). Emerging themes in structural biology of neurotrophic factors. Trends Neurosci. 21, 438-444.
26. Johansson M., Norrgard O. and Forsgren S. (2007). Study of expression patterns and levels of neurotrophins and neurotrophin receptors in ulcerative colitis. Inflamm. Bowel. Dis. 13, 398-409.
27. Johnson D., Lanahan A., Buck C.R., Sehgal A., Morgan C., Mercer E., Bothwell M. and Chao M. (1986). Expression and structure of the human NGF receptor. Cell 47, 545-554.
28. Kajikawa Y., Morihara T., Sakamoto H., Matsuda K., Oshima Y., Yoshida A., Nagae M., Arai Y., Kawata M. and Kubo T. (2008). Platelet-rich plasma enhances the initial mobilization of circulationderived cells for tendon healing. J. Cell. Physiol. 215, 837-845.
29. Khan K.M., Cook J.L., Bonar F., Harcourt P. and Astrom M. (1999). Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med. 27, 393-408.
30. Korsching S. (1993). The neurotrophic factor concept: a reexamination. J. Neurosci. 13, 2739-2748.
31. Kumar A., Sinha R.A., Tiwari M., Pal L., Shrivastava A., Singh R., Kumar K., Kumar Gupta S. and Godbole M.M. (2006). Increased pro-nerve growth factor and p75 neurotrophin receptor levels in developing hypothyroid rat cerebral cortex are associated with enhanced apoptosis. Endocrinology 147, 4893-4903.
32. Levi-Montalcini R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1162.
33. Levi-Montalcini R., Aloe L. and Alleva E. (1990). A role for nerve growth factor in nervous, endocrine and immune system. Prog. Neuroendocrinimmunol. 3, 1-10.
34. Lian O., Scott A., Engebretsen L., Bahr R., Duronio V. and Khan K. (2007). Excessive apoptosis in patellar tendinopathy in athletes. Am. J. Sports Med. 35, 605-611.
35. Linnarsson S., Willson C.A. and Ernfors P. (2000). Cell death in regenerating populations of neurons in BDNF mutant mice. Brain Res. Mol. Brain Res. 75, 61-69.
36. Lommatzsch M., Niewerth A., Klotz J., Schulte-Herbruggen O., Zingler C., Schuff-Werner P. and Virchow J.C. (2007). Platelet and plasma BDNF in lower respiratory tract infections of the adult. Respir. Med. 101, 1493-1499.
37. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P. and Virchow J.C. (2005). The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 26, 115-123.
38. Ma D., Wolvers D., Stanisz A.M. and Bienenstock J. (2003). Interleukin- 10 and nerve growth factor have reciprocal upregulatory effects on intestinal epithelial cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R1323-1329.
39. Maffulli N., Testa V., Capasso G., Ewen S.W., Sullo A., Benazzo F. and King J.B. (2004). Similar histopathological picture in males with Achilles and patellar tendinopathy. Med. Sci. Sports Exerc. 36, 1470-1475.
40. Manni L. and Aloe L. (1998). Role of IL-1 beta and TNF-alpha in the regulation of NGF in experimentally induced arthritis in mice. Rheumatol. Int. 18, 97-102.
41. Manni L., Lundeberg T., Fiorito S., Bonini S., Vigneti E. and Aloe L. (2003). Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. Clin. Exp. Rheumatol. 21, 617-624.
42. Martin-Zanca D., Oskam R., Mitra G., Copeland T. and Barbacid M. (1989). Molecular and biochemical characterization of the human trk proto-oncogene. Mol. Cell. Biol. 9, 24-33.
43. Merighi A., Salio C., Ghirri A., Lossi L., Ferrini F., Betelli C. and Bardoni R. (2008). BDNF as a pain modulator. Prog. Neurobiol. 85, 297-317.
44. Muangman P., Muffley L.A., Anthony J.P., Spenny M.L., Underwood R.A., Olerud J.E. and Gibran N.S. (2004). Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen. 12, 44-52.
45. Nockher W.A. and Renz H. (2005). Neurotrophins in clinical diagnostics: pathophysiology and laboratory investigation. Clin. Chim. Acta 352, 49-74.
46. Reinshagen M., Rohm H., Steinkamp M., Lieb K., Geerling I., Von Herbay A., Flamig G., Eysselein V.E. and Adler G. (2000). Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology 119, 368-376.
47. Riley G. (2005). Chronic tendon pathology: molecular basis and therapeutic implications. Expert Rev. Mol. Med. 7, 1-25.
48. Safieh-Garabedian B., Poole S., Allchorne A., Winter J. and Woolf C.J. (1995). Contribution of interleukin-1 beta to the inflammationinduced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115, 1265-1275.
49. Schulte-Herbruggen O., Nassenstein C., Lommatzsch M., Quarcoo D., Renz H. and Braun A. (2005). Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J. Neuroimmunol. 160, 204-209.
50. Scott A., Alfredson H. and Forsgren S. (2008). VGluT2 expression in painful Achilles and patellar tendinosis: evidence of local glutamate release by tenocytes. J. Orthop Res. 26, 685-692.
51. Takei Y. and Laskey R. (2008). Interpreting crosstalk between TNFalpha and NGF: potential implications for disease. Trends. Mol. Med. 14, 381-388.
52. Virchenko O., Grenegard M. and Aspenberg P. (2006). Independent and additive stimulation of tendon repair by thrombin and platelets. Acta Orthop. 77, 960-966.
53. Wang Y.Q., Bian G.L., Bai Y., Cao R. and Chen L.W. (2008). Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Neurochem. Int. 53, 56-62.
54. Woolf C.J., Safieh-Garabedian B., Ma Q.P., Crilly P. and Winter J. (1994). Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62, 327-331.
55. Yamashiro T., Fukunaga T., Yamashita K., Kobashi N. and Takano- Yamamoto T. (2001). Gene and protein expression of brain-derived neurotrophic factor and TrkB in bone and cartilage. Bone 28, 404-409.
56. Zhu Z., Friess H., Shi X., Wang L., di Mola F.F., Wirtz M., Hartel M., Wagner M., Zimmermann A., Muller M. and Buchler M.W. (2003). Up-regulation of p75 neurotrophin receptor (p75NTR) is associated with apoptosis in chronic pancreatitis. Dig. Dis. Sci. 48, 717-725.